Rocket


Overview
Financials
News + Filings

 
 

EMULATE THERAPEUTICS, INC. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20
Revenues1.52.1
            Revenue growth-25.6% 
Cost of goods sold11.610.7
Gross profit-10.0-8.7
            Gross margin-653.2%-420.8%
General and administrative10.08.7
EBIT-11.3-10.6
            EBIT margin-737.5%-515.3%
Pre-tax income0.02.6
Income taxes0.0-0.8
Net income-22.13.5
            Net margin-1438.3%167.5%
 
Diluted EPS($1.61)$0.18
Shares outstanding (diluted)13.719.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy